Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction
Status:
Withdrawn
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
Currently there are few therapeutic options for the treatment of lid retraction secondary to
thyroid orbitopathy (TO) during the active stages of the disease. BoTox injection is capable
of creating a ptosis, that in the setting of TO can return the upper lid to a more
physiologic position, thus improving cosmesis, corneal lubrication and potentially quiescent
stage lid position. This investigation aims to examine the properties of this relationship.
Phase:
Phase 4
Details
Lead Sponsor:
University of Toronto
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA